LFCR241220P12500
- 7.60
- 0.000.00%
Lifecore Biomedical Newsroom
Express News | Lifecore Biomedical Inc - Credit Facility Term Extended to November 2027
Express News | Lifecore Biomedical Amends and Extends Revolving Credit Facility With BMO
Press Release: Lifecore Biomedical Amends and Extends Revolving Credit Facility With BMO
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $10
Barrington Remains a Hold on Lifecore Biomedical (LFCR)
Lifecore Biomedical Hosts Virtual Investor Day
Lifecore Biomedical Plans Strategic Growth and Transformation
US Manufacturing Index Rises To 43, Highest Since 2020
Here's Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)
Lifecore Biomedical to Present at Stephens Annual Investment Conference
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Top Owners Are Retail Investors With 35% Stake, While 35% Is Held by Hedge Funds
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock Rockets 42% But Many Are Still Ignoring The Company
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Express News | Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Lifecore Biomedical GAAP EPS of -$0.53, Revenue of $24.7M
Lifecore Biomedical Files Secondary Stock Shelf
Wynnefield Entities Buy $1.2m of Lifecore Biomedical Stock
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $8
Barrington Maintains Lifecore Biomedical(LFCR.US) With Hold Rating